Literature DB >> 28449044

Vernakalant does not alter early repolarization or contractility in normal and electrically remodelled atria.

Arne van Hunnik1, Hussein Nasrallah1, Dennis H Lau1, Marion Kuiper1, Sander Verheule1, Ulrich Schotten1.   

Abstract

Aims: Besides the inhibition of the sodium inward current, vernakalant also inhibits the ultra rapid rectifier (IKur) and transient outward current (Ito). Inhibition of these currents increases contractility in canine atrial myocytes and goat atria. We investigated the effect of vernakalant on early repolarization and contractility in normal and electrically remodelled atria. Methods and results: Goats were implanted a pressure catheter, piezoelectric crystals, and electrodes to obtain atrial contractility and effective refractory period (ERP). The active component in pressure distance loops was used to compute the atrial work index (AWI). Experiments were performed in normal and electrically remodelled atria at clinically relevant plasma levels of vernakalant. As a positive control, the Ito/IKur blocker AVE0118 was investigated. Monophasic action potentials were recorded in anaesthetized goats and in explanted hearts to determine changes in action potential morphology. Vernakalant did not affect atrial work loops during sinus rhythm. Likewise vernakalant did not increase atrial fractional shortening or AWI during pacing with fixed heart rate and AV-delay. In contrast, AVE0118 did increase AWI, with a positive force frequency relation. Both in normal and remodelled atria, vernakalant strongly increased ERP but did not prolong early repolarization.
Conclusion: In goat atria, vernakalant does not have an atrial positive inotropic effect and does not affect early repolarization. At high rates vernakalant may even have a negative inotropic effect. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Action potential; Atrial fibrillation; Contractility; Ion current; Remodeling ; Repolarization; Vernakalant

Mesh:

Substances:

Year:  2018        PMID: 28449044     DOI: 10.1093/europace/eux025

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  1 in total

1.  The Acetylcholine-Activated Potassium Current Inhibitor XAF-1407 Terminates Persistent Atrial Fibrillation in Goats.

Authors:  Vladimír Sobota; Giulia Gatta; Arne van Hunnik; Iris van Tuijn; Marion Kuiper; James Milnes; Thomas Jespersen; Ulrich Schotten; Sander Verheule
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.